Legal Representation
Attorney
Nicole Kinsley,
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 19, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 18, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 14, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 13, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 13, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 8, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 8, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Oct 4, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 2, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 2, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 2, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 13, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 13, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 13, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 12, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 10, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 10, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 10, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 8, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 6, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 6, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 12, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 17, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 17, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 27, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 6, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 12, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 11, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 11, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 1, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 27, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 27, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 23, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 23, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 23, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 31, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 31, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 31, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 29, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 27, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pain relief medication and hormones for medical purposes; vaccines; immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of patches that provide transdermal delivery of the active ingredient for a wide range of pharmaceuticals; drug delivery agents in the form of polymers that facilitate the sustained release of a wide range of pharmaceuticals; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with vaccines; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with immunotherapies for the treatment of cancer, autoimmune diseases or disorders, and allergies; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with pain relief medication; drug delivery agents in the form of resorbable microneedles that facilitate the transdermal delivery of pharmaceuticals, pre-filled with hormones for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005